Fred Alger Management’s Structure Therapeutics GPCR Stock Holding History

Fred Alger Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-66,662	Closed	-$1.81M	–	438
2024 Q4	$1.81M	Sell	66,662 -51	-0.1%	-$1.81K	0.01%	336
2024 Q3	$2.93M	Sell	66,713 -220,923	-77%	-$8.54M	0.01%	296
2024 Q2	$11.3M	Sell	287,636 -125,741	-30%	-$5.16M	0.05%	179
2024 Q1	$17.7M	Buy	413,377 +122,280	+42%	+$5.16M	0.09%	155
2023 Q4	$11.9M	Buy	291,097 +191,757	+193%	+$11M	0.06%	169
2023 Q3	$5.01M	Buy	99,340 +88,828	+845%	+$2.86M	0.03%	237
2023 Q2	$437K	Buy	+10,512	New	+$295K	﹤0.01%	403

Other funds holding GPCR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fred Alger Management's GPCR Position: Q1 2025 in Review

Fred Alger Management sold out of Structure Therapeutics (GPCR) in Q1 2025, closing a stake of 66,662 shares — an estimated $1.81M sold.

Fred Alger Management first reported a position in GPCR in Q2 2023 and held it in 7 quarters. The position peaked at $17.7M in Q1 2024. 150 funds tracked by Wall St. Rank hold GPCR as of Q1 2025.

Fred Alger Management reported no remaining Structure Therapeutics position as of Q1 2025 after selling out during the quarter.
Fred Alger Management sold 66,662 Structure Therapeutics shares in Q1 2025, an estimated $1.81M.
Fred Alger Management first reported a position in Structure Therapeutics in Q2 2023 and held it in 7 quarters.
Fred Alger Management's Structure Therapeutics position peaked at $17.7M in Q1 2024.
150 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2025.

Based on Fred Alger Management's 13F filing for Q1 2025, filed 16 May 2025.